Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-073864
Filing Date
2023-12-29
Accepted
2023-12-29 16:30:19
Documents
2
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6882
2 EX-24.1 nams-ex24_1.htm EX-24.1 16163
  Complete submission text file 0000950170-23-073864.txt   24575
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address
Kastelein Johannes Jacob Pieter (Reporting) CIK: 0002000389 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41562 | Film No.: 231528075